Neurology: Volume 92, Number 7, February 12, 2019 Exam #1 - RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome
About this course
- Released: 02/12/2019
- Expires: 02/12/2022
RCVS2 SCORE AND DIAGNOSTIC APPROACH FOR REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME
LEARNING OBJECTIVES:
Upon completion of the article by Rocha et al, the participant should be able to:
- Discuss differences in the rates at which specific intracranial blood vessels were affected in patients with reversible cerebral vasoconstriction syndrome (RCVS) and in patients with other forms of cerebral vasculopathies included in this study
- State the sensitivity and specificity for the RCVS2 score at various cutpoints to diagnose RCVS or other causes of intracranial vasculopathy found in this study
- Identify specific patient-level characteristics associated with a diagnosis of RCVS in patients with an intermediate RCVS2 score in this study
CORE COMPETENCIES:
The article by Rocha et al covers the following core competency:
- Medical Knowledge
AUTHOR DISCLOSURES:
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
AMA CREDIT DESIGNATION STATEMENT
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURES
James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology. Adam Kelly, MD, has served as a guest editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.
COMMERCIAL SUPPORT
This CME program receives no commercial support.